WIVI Vision
WIVI Vision is a CE-marked medical device combining software with dedicated hardware. Sold to eye-care professionals, it assesses more than 100 visual parameters in 10 minutes, then delivers AI-personalised 3D video-game training for non-strabismic binocular dysfunctions.
What is WIVI Vision?
WIVI Vision is a visual efficiency assessment and training solution that combines software with dedicated hardware. It is published by E-Health Technical Solutions SL, a spin-off of the Universitat Politècnica de Catalunya based in Barcelona, with an announced presence the site sums up as 'Barcelona - Berlin'. The company was built by Eva García Ramos, a telecommunications engineer who serves as CEO, and Dr Juan Carlos Ondategui-Parra, an optometrist, PhD and associate professor at FOOT-UPC. The clinical scope is narrow and stated plainly: non-strabismic binocular dysfunctions. That covers accommodative excess, insufficiency and infacility, convergence excess and insufficiency, diplopia, pursuit deficiencies, vergence infacility and vertical deviations. Assessment runs through immersive 3D video games and measures more than 100 parameters across five visual areas in around 10 minutes, ending in a report on the patient's visual capabilities. The training that follows is personalised by AI: programmes run one and a half to three months, in sessions of 20 minutes, again delivered as 3D games. Beyond the core clinical use, the company markets modules for progressive lens adaptation, reading skills, digital eye strain, sport, and optimisation for people with no diagnosed dysfunction. The stated age range is 7 to 99. The regulatory position is the most solid published element. The device carries CE marking and, according to the company's own news posts, was certified as a class IIa medical device in August 2026, having previously been class I. ISO 13485 was obtained in March 2026 under audit by TÜV SÜD, and a medical device manufacturing licence was issued by the Spanish agency AEMPS. FDA registration is claimed, along with an innovative SME seal from the Spanish science ministry. Effectiveness statements, by contrast, should be read as vendor claims: the site advertises '100% effectiveness and no regressions' and full recovery of symptoms in less than three months without linking to any published study. The company frames the problem as 40% of the population having visual efficiency issues while only 2% are treated. Distribution is strictly business to business: the solution is sold to accredited vision professionals and deployed inside their centres, training and support included. There is no consumer edition, no mobile app, no API and no public price.
What it does
- Assess more than 100 visual parameters across five visual areas in about 10 minutes
- Produce a detailed report diagnosing the patient's visual capabilities
- Prescribe a personalised visual training programme of one and a half to three months, in 20-minute sessions
- Deliver that training as immersive 3D video games, personalised by AI for each patient
- Track progress through objective, real-time measurements
- Detect non-strabismic binocular dysfunctions, from accommodative and convergence disorders to vergence infacility
- Address specific use cases: reading, digital eye strain, progressive lens adaptation and sports performance
When to use WIVI Vision / When not to
A quick filter to help you decide if WIVI Vision is the right fit.
When to use WIVI Vision
- Opticians and optometrists who want to add visual assessment and vision therapy to what their practice already offers.
- Ophthalmologists and paediatric clinics looking to detect binocular dysfunctions that are often mistaken for dyslexia or attention disorders.
- Sports medicine departments and performance coaches working on reaction time, eye-hand coordination and object tracking.
- Optical chains and buying groups after a differentiating service, in line with the site's pitch of a more profitable optical business.
- Vision-care centres that want a turnkey package, with the hardware, staff training and ongoing clinical support included.
When not to use WIVI Vision
- Consumers hoping to self-assess or self-train at home: the solution is sold to accredited professionals and used on their premises.
- Patients with strabismus, since the published clinical scope is explicitly limited to non-strabismic binocular dysfunctions.
- Children under seven, which is the minimum age the company states for use of the device.
- Developers and IT teams looking for an API, a mobile app or public technical documentation, none of which exists.
- Buyers who need a published price list or a free trial before speaking to sales, as every purchase goes through a quote.
How to use WIVI Vision
A typical end-to-end flow, from setup to results.
- Send a 'Request a Demo' enquiry through the contact form, choosing a demonstration, a call back or an information pack
- Or fill in the centre form with your name, email, phone number, centre name, city and profession to be contacted by the team
- Discuss your centre's needs so the company can estimate a price for your segment, since no rate is published
- Buy the solution as a package, delivered with all the materials needed to use it from day one
- Take the training provided by the WIVI team and have the system installed, which the company says takes only a few days
- Run the 10-minute assessment with a patient: more than 100 parameters across five visual areas, played as 3D video games
- Go through the detailed report describing the patient's visual capabilities
- Prescribe the personalised training programme: 20-minute sessions over one and a half to three months
- Follow progress using the objective measurements the sessions produce
- As a patient, use the 'Find WIVI' form to be put in touch with the nearest equipped centre, as there is no browsable directory
Pros & Cons
Pros
- Strong, verifiable regulatory status: CE marking, class IIa medical device certification, ISO 13485 audited by TÜV SÜD and an AEMPS manufacturing licence
- A bounded treatment window, which the company presents as the only solution offering a defined timeline of one and a half to three months
- Short assessment time, around 10 minutes for more than 100 parameters, against far longer conventional workups
- Patient adherence is designed in, through immersive 3D games and short 20-minute sessions
- Scientific grounding: collaborations with the UPC, EIT Health and IBM, more than 30 public and private hospital centres, and a clinical study with the Consorci Sanitari de Terrassa
- Turnkey for the centre, with hardware, training and continuous support bundled into the solution
- Backed by a funding round of 4 million closed in March 2024 and by more than 100 awards the company claims
Cons
- No public pricing whatsoever: the Kit Digital page states the price is estimated according to the client's segment and specific needs
- No free trial and no free plan is published anywhere on the site
- No API, no mobile app and no public technical documentation
- Nothing is published about where data is hosted, neither country nor region, and there is no trust or security page
- No data processing agreement, no sub-processor list and no model-training opt-out is mentioned
- The privacy policy covers website data only and says nothing about patients' clinical data, which is notable for a medical device; the legal documents carry no effective date and no version number
- Access depends on finding an equipped centre, since a patient cannot buy or use the solution independently, and the '100% effectiveness and no regressions' claim is not backed on the site by any published study reference
Pricing & Plans
No price is published anywhere on the site and there is no pricing page, which was checked against the complete sitemap rather than the navigation alone. The Kit Digital page is the only place that addresses the question, and it states that the price of the solution will be estimated based on the segment to which the beneficiary belongs and the specific needs of each client. Every purchase therefore goes through a commercial quote. No free plan and no free trial is announced. The site does claim the treatment is ten times cheaper than conventional treatment, but that is a relative comparison put forward by the company, not a published amount, and no currency or billing unit appears anywhere on the site.
Data, GDPR & hosting
A consolidated view of how WIVI Vision handles your data.
GDPR overview
GDPR implementation is explicit for the website, even though the company never writes the words 'GDPR compliant'. The privacy policy names the controller, cites consent under Article 6.1.a as the legal basis, and lists the six data subject rights: access, rectification, erasure, restriction, objection and portability. Consent can be withdrawn by email to rgpd@ehealthts.com. A Data Protection Officer is designated under Article 37, through an external consultancy. The Spanish supervisory authority, the Agencia Española de Protección de Datos, is named as the body to complain to. The policy also declares that no international transfers take place and that no profiling or automated decision-making is carried out. The gaps are real too: no effective date, no version number, no data processing agreement, no sub-processor list, and not a word about the clinical data the device itself collects.
Who owns the data?
The privacy policy names E-HEALTH TECHNICAL SOLUTIONS, S.L. (NIF B66773268) as the data controller, and the same company claims intellectual property over the site's content. A Data Protection Officer is designated, but the contact point is an outside consultancy rather than an in-house address. The important limitation is one of scope: the policy only covers personal data collected through the website, such as contact and demo request forms. It says nothing about who owns or controls the clinical data generated by patients during assessment and training sessions, which is a notable gap for a certified medical device. No data processing agreement and no sub-processor list is published.
Reuse rights
According to the privacy policy, personal data is processed to deliver the services the user has subscribed to, on the basis of consent under Article 6.1.a of the GDPR and of legitimate interest for the commercial relationship. The policy states that no international transfers will be made and that, in its own words, 'neither profiles are developed nor automated decisions are taken with the data you provide'. Data is not passed to third parties except where that is necessary to carry out or monitor the stated purpose, or where the law requires it. Nothing grants the end user a right to reuse content: the terms of use reserve the site's intellectual property to the publisher, and no licence is described that would let a professional or a patient reuse assessment results, reports or training data without asking. Reuse rights over clinical outputs are simply not addressed.
Data retention & training
Hosting summary
The site publishes no hosting information at all: no country, no region, no cloud provider, and there is no trust or security page anywhere. The one related statement sits in the privacy policy, which says that no international transfers will be made. That is a declaration about transfers rather than a location, and it names no country. No sub-processor list is published and no data processing agreement is offered. For the record, the website itself resolves to an IP address in France, on infrastructure operated by the German provider Contabo. That is where the marketing site is served from and nothing more: it says nothing about where patients' clinical data is stored or processed, and the company makes no statement on that point. Since WIVI Vision is a certified medical device handling health data, the absence of a published hosting jurisdiction is a question to put to the vendor directly, together with the terms governing the clinical records generated during assessment and training.
Things to keep in mind
Risks and trade-offs to weigh before adopting WIVI Vision.
- Effectiveness is advertised in absolute terms, '100% effectiveness and no regressions' and full symptom recovery in under three months, with no published study referenced on the site. Treat these as vendor claims and ask for the evidence before relying on them clinically or repeating them to patients.
- The privacy policy covers website data only. It says nothing about the clinical data the device collects from patients, who owns it, how long it is kept or where it is stored, which is the single biggest documentation gap for a certified medical device.
- The site contradicts itself on the number of parameters measured: more than 100 on the home page and the product pages, but over 50 on the Kit Digital page.
- Two different company addresses are published: Avenida Diagonal 131 in the terms of use and on the contact page, Via Laietana 26 in the privacy policy. The privacy policy is the isolated exception and looks out of date.
- In the privacy policy, the text invites you to write to the company's own GDPR address but the underlying mailto link points to an unrelated third party, apparently a template leftover. Use the address written in the text, not the link.
- The terms of use assign jurisdiction to the courts of Bilbao although the company is registered and based in Barcelona, and neither the terms nor the privacy policy carries an effective date or a version number.
- The Kit Digital subsidy shown on the site closed in October 2025 but the page is still online, so it can read as a live offer; and every published email address sits on the publisher's ehealthts.com domain, never on wivivision.com.
Setup & Integrations
Technical difficulty
Low, on the company's own account. The centre buys a package that arrives with all the materials needed to use it from day one, and the site describes easy installation with a purchase process measured in a few days. Full training and ongoing support are provided by the WIVI team, and there is no technical integration to carry out: no API, no connector and no documented single sign-on. What is not published is the technical prerequisites, such as space, computer or display requirements and network needs, so confirm them during the demo rather than assuming.
Behind WIVI Vision
Fundraising
Social
Resources
All the official URLs gathered for verification and reference.
Frequently asked questions
What does WIVI Vision actually do?
Who is it for?
Which conditions does it address?
How long does a treatment programme last?
How much does it cost?
Is WIVI Vision a certified medical device?
Is there an API or a mobile app?
How can I try it before buying?
Where is the data hosted?
Who publishes WIVI Vision?
Should you pick WIVI Vision?
WIVI Vision is one of those tools whose credibility rests on regulatory paperwork rather than on marketing: CE marking, class IIa medical device certification, ISO 13485 audited by TÜV SÜD and a manufacturing licence from the Spanish medicines agency are all named and dated on the site. Add a spin-off origin at the Universitat Politecnica de Catalunya, collaborations with the UPC, EIT Health and IBM, work with more than 30 hospital centres, a funding round of 4 million closed in March 2024 and partnerships with optical groups in Spain and Portugal, and the clinical proposition looks serious. The reservations are commercial and documentary. There is no price anywhere, no free trial, no free plan, and the only pricing statement on the site says the figure is estimated case by case. For a certified medical device the published documentation is thin: no technical specification, no API, no trust or security page, no data processing agreement, no sub-processor list, and a privacy policy that covers the website but never mentions the clinical data the device collects from patients. Effectiveness is advertised in absolute terms, '100% effectiveness and no regressions', with no study reference on the site, which is exactly the kind of claim a buyer should ask to see evidenced. The real customer here is the vision-care centre, not the end user. A patient cannot buy, download or try anything: they fill in a form and are directed to an equipped centre. For an optician, an optometry chain or a sports performance department, WIVI Vision is a plausible turnkey addition worth a demo request, provided the questions of price, data hosting and clinical evidence are put directly to the sales team. For anyone expecting a self-service AI product, this is the wrong shelf.
- Choosing a selection results in a full page refresh.
- Opens in a new window.